MedTrace Logo

Comparison Airway Devices in Nasotracheal Intubation in Manikin

NCT01311284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2012-01-05

No results posted yet for this study

Summary

Nasotracheal intubation is usually required in oral surgery to allow an unrestricted surgical approach. The standard method is generally performed using the Macintosh laryngoscope supported by Magill forceps. However, it is recommended to perform awake tracheal intubation in situations where a difficult airway is predicted, a scenario where this technique may be poorly tolerated by the patient. Although fibreoptic intubation is considered the "gold standard", sometimes it is difficult to perform and,therefore, alternatives are necessary. The hypothesis is that optical laryngoscopes as the Airtraq nasotracheal and Mcgrath can improve the time and/or success of nasotracheal intubation in a manikin.

Conditions

  • Nasotracheal Intubation

Interventions

DEVICE

Macintosh laryngoscope, Airtraq NT, Mcgrath laryngoscope

Each participant will use the Macintosh laryngoscope (blade No. 3), laryngoscope Airtraq NT and Mcgrath Laryngoscope under conditions of normal and difficult airway in different simulated scenarios.

DEVICE

Macintosh laryngoscope

intubate with the macintosh laryngoscope

DEVICE

McGrath

Intubate with McGrath device

DEVICE

Airtraq Nasotracheal

intubate with Airtraq Nasotracheal

Sponsors & Collaborators

  • Manuel Ángel Gómez-Ríos

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
23 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01311284 on ClinicalTrials.gov